Page 152 - Read Online
P. 152

Khaitan et al. Mini-invasive Surg 2020;4:51  I  http://dx.doi.org/10.20517/2574-1225.2020.34                                     Page 11 of 14

               robotic cancer operations is on the rise [28,29] . A major advantage of current robotic systems, compared to
               the performance of an open esophagectomy, is the seven degrees-of-freedom in the wristed instruments,
               allowing the surgeon to operate ergonomically with angulation comparable to the human wrist. This
               dexterity allows the surgeon to complete esophageal and nodal dissections similar to an open procedure,
               facilitates intracorporeal suturing and knot tying, and enhances the surgeon’s ability to operate in difficult-
               to-reach places such as the apex of the chest, subcarinal space, and splenic flexure. The additional
               advantages of current robotic platforms include three-dimensional visualization, 10-fold magnification, and
               a 6-Hertz motion filter designed to eliminate tremor. In addition, robotic surgical platforms offer longer
               instruments compared to other minimally invasive systems with a fixed fulcrum supported by robotic
               arms, potentially leading to reduced stress on the chest and abdominal wall. An operating console for a
               second surgeon is used in some robotic operating rooms, allowing surgeons to perform surgery in tandem
               with, and facilitating training in a dynamic and supportive manner.

               Given these advantages, the increasing utilization of surgical robotics in the performance of esophagectomy
               should come as no surprise. While the initial experiences with RAMIE were associated with higher
               complication rates, subsequent reports have shown that RAMIE can be performed with superior
               perioperative outcomes, and equivalent oncologic survival when compared to open and traditional
               minimally invasive approaches [14,15] . Such experiences suggest that the potential disadvantages of current
               surgical robots, including the lack of haptic feedback and the positioning of the surgeon at a remote console
               in a non-sterile environment, can be mitigated by surgeon experience and the presence of trained assistants
               in the sterile field. The incidence of associated complications, such as major uncontrolled hemorrhage,
               appears to be at an acceptably low level.

               Ongoing studies about RAMIE
               Numerous retrospective studies have supported the role of MIE and RAMIE when compared to open
               esophagectomy. Only a limited number of prospectively designed, randomized controlled trials (RCTs),
               however, have been reported to date. An RCT of 115 patients from 5 European centers (the TIME trial)
               evaluated the outcomes of 59 patients randomly assigned to MIE compared to 56 patients randomized to
                                                                                              [1,4]
               open esophagectomy. Initial results were published in 2012, and long-term results in 2017 . While the
               baseline demographics and clinical characteristics were similar in both groups, the overall 3-year survival
               was higher in the MIE group (50.5% vs. 40.4%), although the difference was not statistically significant (P =
               0.207). Disease-free 3-year survival rates were also similar between the two groups [40.2% for MIE, 35.9%
               for open; HR = 0.691 (95%CI: 0.389-1.239)]. Of note, pulmonary complications were significantly lower in
               the MIE group (12% vs. 34%, P = 0.005), as was blood loss (200 mL vs. 475 mL, P < 0.001) and hospital stay
               (11 days vs. 14 days, P = 0.044) despite conversions from MIE to open in eight cases. The anastomotic leak
               rate, re-operative rates, and 30-day mortality rates were similar between groups.

                                                                                                 [5]
               The ROBOT trial, published in 2019, was an RCT from a single institution in the Netherlands . Patients
               with esophageal cancer were randomized to RAMIE (n = 54) or open esophagectomy (n = 55). Findings
               were similar to those from TIME, with less overall surgery-related complications following RAMIE (59%
               vs. 80%; P = 0.02), fewer pulmonary complications (32% vs. 58%; P = 0.005), and a lower incidence of atrial
               fibrillation (22% vs. 46%, P = 0.01). On the contrary, no differences were noted in anastomotic leak rates or
               mortality rates between the two groups. Median ICU stay, hospital stay, R0 resection rates, and lymph node
               retrieval numbers were not significantly different between the two groups. Functional recovery, patient
               reported pain scores, and short-term quality of life assessments all favored the RAMIE approach. Overall,
               the study found improved short-term outcomes following robotic esophagectomy compared to the open
               approach.


               While several retrospective studies, as well as these RCTs, have compared both MIE and RAMIE to open
               esophagectomy, no studies have compared RAMIE to MIE. A recently opened trial (RAMIE trial) is
   147   148   149   150   151   152   153   154   155   156   157